Results 221 to 230 of about 1,436,143 (281)

A Security-Enhanced Certificateless Aggregate Authentication Protocol with Revocation for Wireless Medical Sensor Networks. [PDF]

Sensors (Basel)
Fan Q, Wang Y, Li X.
europepmc   +1 more source

Value of MRI Outcomes for Preventive and Early‐Stage Trials in Spinocerebellar Ataxias 1 and 3

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the value of MRI outcomes as endpoints for preventive and early‐stage trials of two polyglutamine spinocerebellar ataxias (SCAs). Methods A cohort of 100 participants (23 SCA1, 63 SCA3, median Scale for the Assessment and Rating of Ataxia (SARA) score = 5, 42% preataxic, and 14 gene‐negative controls) was scanned at 3T up ...
Thiago J. R. Rezende, Emilien Petit, Young Woo Park, Sophie Tezenas du Montcel, James M. Joers, Jonathan M. DuBois, H. Moore Arnold, Michal Povazan, Ipek Özdemir, Guita Banan, Romain Valabregue, Philipp Ehses, Jennifer Faber, Chiadi U. Onyike, Peter B. Barker, Jeremy D. Schmahmann, Eva‐Maria Ratai, Sub H. Subramony, Thomas H. Mareci, Khalaf O. Bushara, Henry Paulson, Thomas Klockgether, Alexandra Durr, Tetsuo Ashizawa, Christophe Lenglet, Gülin Öz, READISCA Investigators   +26 more
wiley   +1 more source

A pyroptosis-related gene signature for the diagnosis of acute pancreatitis. [PDF]

PLoS One
Wang Y, Li J, Yu Z, Li S, Chen Y, Pan Y, Cheng L, Yu G.   +7 more
europepmc   +1 more source

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher, Charles B. Malpas, Stuart J. McDonald, William T. O’Brien, Craig Despott, Kelly L. Bertram, Matthew P. Pase, Lukas Frontzkowski, Meng Law, Terence J. O’Brien, Lucy Vivash   +10 more
wiley   +1 more source

From a Multi-Omics Signature to a Therapeutic Candidate: Computational Prediction and Experimental Validation in Liver Fibrosis. [PDF]

Pharmaceuticals (Basel)
Qin Y, Ma S, Hong H, Zhong D, Liang Y, Su Y, Chen Y, Chen X, Zhu Y, Huang X.   +9 more
europepmc   +1 more source

Identification of Paraptosis-Related Renal Cell Carcinoma Subtypes, Construction of a Prognostic Signature, and Determination of Tumor Microenvironment Landscape Using Bioinformatic Analysis and Experimental Verification. [PDF]

Curr Issues Mol Biol
Qin M, Chen M, Gan Y, Feng X, Huang P, Meng F, Yang Y.   +6 more
europepmc   +1 more source

Translating Molecular Subtypes into Cost-Effective Radiogenomic Biomarkers for Prognosis of Colorectal Cancer. [PDF]

Diagnostics (Basel)
Gai B, Duan X, Li C, Hu C, Lv M, Lei J, Wang R, Gao F, Cai D.   +8 more
europepmc   +1 more source

Integrated Multi-Omics Analysis Constructs an Intratumoral Heterogeneity-Corrected Prognostic Signature for Cervical Cancer. [PDF]

Int J Gen Med
Tang X, Zheng Q, Li X, Wang K.
europepmc   +1 more source

A deep learning radiopathomic signature predicts recurrence risk of hepatocellular carcinoma after hepatectomy. [PDF]

Commun Biol
Wang G, Chen W, Liang Z, Ding F, Cui J, Shen Z, Lin F, Li X, Wang X, Zhao X.   +9 more
europepmc   +1 more source

Longitudinal monitoring of type 1 diabetes progression to disease onset. [PDF]

Sci Adv
King JL, Roy J, Urie RR, Bealer E, Crumley K, Rad L, Soleimanpour SA, Shea LD.   +7 more
europepmc   +1 more source